Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Joanne Cresswell"'
Autor:
Rakesh Heer, Rebecca Lewis, Anne Duncan, Steven Penegar, Thenmalar Vadiveloo, Emma Clark, Ge Yu, Paramananthan Mariappan, Joanne Cresswell, John McGrath, James N’Dow, Ghulam Nabi, Hugh Mostafid, John Kelly, Craig Ramsay, Henry Lazarowicz, Angela Allan, Matthew Breckons, Karen Campbell, Louise Campbell, Andy Feber, Alison McDonald, John Norrie, Giovany Orozco-Leal, Stephen Rice, Zafer Tandogdu, Ernest Taylor, Laura Wilson, Luke Vale, Graeme MacLennan, Emma Hall
Publikováno v:
Health Technology Assessment, Vol 26, Iss 40 (2022)
Background: Around 7500 people are diagnosed with non-muscle-invasive bladder cancer in the UK annually. Recurrence following transurethral resection of bladder tumour is common, and the intensive monitoring schedule required after initial treatment
Externí odkaz:
https://doaj.org/article/ecfa1b558cb8431b8aeeac631a9bd218
Autor:
Sufyan Ibrahim, Amelia Pietropaolo, Nithesh Naik, Anita Patel, Milap J. Shah, Patricia Zondervan, Jean McDonald, BM Zeeshan Hameed, Bhavan Prasad Rai, Hadis Karimi, Bhaskar K. Somani, Joanne Cresswell
Publikováno v:
Archivio Italiano di Urologia e Andrologia, Vol 93, Iss 4 (2021)
Background: Urology, traditionally a maledominated specialty, keeping pace with the quickly changing gender landscape, has been characterized by waves of feminization. This study aims to understand the perspectives of women urologists on the obstacle
Externí odkaz:
https://doaj.org/article/d1f14e47a6ae409194cd78d09e99a933
Autor:
Steven Penegar, Rebecca Lewis, James Catto, Joanne Cresswell, Leyshon Griffiths, Micki Hill, John Kelly, Allen Knight, John McGrath, Laura Wiley, Hugh Mostafid, Emma Hall
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-2 (2018)
Correction After publication of this supplement [1], it was brought to our attention that two authors were missing for abstract P66: Recruitment aids for a phase II randomised trial in low risk bladder cancer. The two missing authors can be found in
Externí odkaz:
https://doaj.org/article/486543635a7e4415a6bbacd02a904df4
Autor:
Wei Shen Tan, Aaron Prendergast, Charlotte Ackerman, Yathushan Yogeswaran, Joanne Cresswell, Paramananthan Mariappan, Jaspal Phull, Paul Hunter-Campbell, Henry Lazarowicz, Vibhash Mishra, Abhay Rane, Melissa Davies, Hazel Warburton, Peter Cooke, Hugh Mostafid, Daniel Wilby, Robert Mills, Rami Issa, John D. Kelly
Publikováno v:
European Urology. 83:497-504
Adjuvant intravesical chemotherapy following tumour resection is recommended for intermediate-risk non-muscle-invasive bladder cancer (NMIBC).To assess the efficacy and safety of adjuvant intravesical chemohyperthermia (CHT) for intermediate-risk NMI
Autor:
Paul Gravestock, Thenmalar Vadiveloo, Rebecca Lewis, Anne Duncan, Steven Penegar, Emma Clark, Ge Yu, Paramananthan Mariappan, Joanne Cresswell, John Mcgrath, James N’dow, Ghulam Nabi, Hugh Mostafid, John Kelly, Craig Ramsay, Henry Lazarowicz, Angela Allan, Matthew Breckons, Karen Campbell, Louise Campbell, Andy Feber, Alison Mcdonald, John Norrie, Giovany Orozco-Leal, Stephen Rice, Zafer Tandogdu, Ernest Taylor, Laura Wilson, Luke Vale, Graeme Maclennan, Emma Hall, Rakesh Heer
Publikováno v:
Journal of Urology. 209
Autor:
James W.F. Catto, Olena Mandrik, Lewis A. Quayle, Syed A. Hussain, John McGrath, Joanne Cresswell, Alison J. Birtle, Rob J. Jones, Paramananthan Mariappan, Lydia E. Makaroff, Allen Knight, Hugh Mostafid, Jim Chilcott, Peter Sasieni, Marcus Cumberbatch
Publikováno v:
Catto, J W F, Mandrik, O, Quayle, L A, Hussain, S A, McGrath, J S, Cresswell, J, Birtle, A J, Jones, R J, Mariappan, P, Makaroff, L E, Knight, A, Mostafid, H, Chilcott, J, Sasieni, P & Cumberbatch, M 2023, ' Diagnosis, treatment and survival from bladder, upper urinary tract, and urethral cancers : real-world findings from NHS England between 2013 and 2019 ', BJU International . https://doi.org/10.1111/bju.15970
OBJECTIVE: We report NHS England data for patients with bladder cancer (BC), upper tract urothelial cancer (UTUC: renal pelvic and ureteric), and urethral cancers from 2013 to 2019.MATERIALS AND METHODS: Hospital episode statistics, waiting times, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ff26a4f128c7f1165aae9f062fab88f
https://www.pure.ed.ac.uk/ws/files/328773453/BJU_International_2023_Catto_Diagnosis_treatment_and_survival_from_bladder_upper_urinary_tract_and_urethral.pdf
https://www.pure.ed.ac.uk/ws/files/328773453/BJU_International_2023_Catto_Diagnosis_treatment_and_survival_from_bladder_upper_urinary_tract_and_urethral.pdf
Autor:
Patricia Hagan, Andrew J. Dickinson, Robert C. Calvert, Jonathan Aning, Christopher Harding, Sarah Fowler, Louisa Hermans, Joanne Cresswell, Su-Min Lee, John S. McGrath, Tharani Nitkunan
Publikováno v:
BJU International. 129:634-641
OBJECTIVES To determine the preoperative assessment and perioperative outcomes of men undergoing bladder outlet obstruction (BOO) surgery in the UK. PATIENTS AND METHODS A retrospective cohort study was conducted of all men undergoing BOO surgery in
Autor:
Samantha Kearley, Pete William Cooke, Aniruddha Chakravarti, Daniel Wilby, Arzu Yousuf, Ahmed Mahrous, Pramit Khetrapal, Krishna Narahari, Islam Abu-Nayla, Benjamin W. Lamb, Rakesh Heer, Howard Kynaston, John D. Kelly, Nikhil Vasdev, Axel Bex, Raj Pal, William Fowler, Omar Al Kadhi, Joanne Cresswell, Mohamed Elajnaf, Ranjan Arianayagam, Jayne Douglas-Moore, T.R. Leyshon Griffiths, George T Hill, Ravi Barod, Jonathan Noel, Alastair McKay, Venkata Rm Kusuma, James Voss, Edward Rowe, Imran Ahmad, Wei Shen Tan
Publikováno v:
European Urology Open Science, Vol 25, Iss, Pp 39-43 (2021)
European Urology Open Science
European Urology Open Science
COVID-19 has resulted in the deferral of major surgery for genitourinary (GU) cancers with the exception of cancers with a high risk of progression. We report outcomes for major GU cancer operations, namely radical prostatectomy (RP), radical cystect
Publikováno v:
BJU International. 128:425-427
Publikováno v:
Journal of Clinical Urology. 14:268-274
Objective: Intravesical bacillus Calmette–Guérin (BCG) is the first-line treatment of choice for high-risk non-muscle-invasive bladder cancer (NMIBC). Our aim was to evaluate the long-term impact of BCG shortages on oncological outcomes. Methods: